Cargando…
Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
Although nivolumab is administered every two or four weeks, high programmed cell death-1 (PD-1) binding of nivolumab on T cells lasting for several months has been reported. A relationship between the PD-1 occupancy rate on T-cells and the efficacy of nivolumab is not yet fully understood. The prese...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022082/ https://www.ncbi.nlm.nih.gov/pubmed/35463212 http://dx.doi.org/10.3892/mco.2022.2537 |